These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 11478352

  • 21. Twice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis.
    Adeboyeku D, Jones AL, Hodson ME.
    J Cyst Fibros; 2011 Jan; 10(1):25-30. PubMed ID: 20920848
    [Abstract] [Full Text] [Related]

  • 22. Amikacin dosing and monitoring in spinal cord injury patients: variation in clinical practice between spinal injury units and differences in experts' recommendations.
    Vaidyanathan S, Peloquin C, Wyndaele JJ, Buczynski AZ, Almog Y, Markantonis SL, Jayawardena V, Soni BM, Cannon J, Vidal J.
    ScientificWorldJournal; 2006 Feb 17; 6():187-99. PubMed ID: 16493523
    [Abstract] [Full Text] [Related]

  • 23. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients.
    Reimann IR, Meier-Hellmann A, Traut T, Reinhart K, Hoffmann A.
    Exp Toxicol Pathol; 2003 Jun 17; 54(5-6):493-8. PubMed ID: 12877363
    [Abstract] [Full Text] [Related]

  • 24. Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial.
    Smyth A, Tan KH, Hyman-Taylor P, Mulheran M, Lewis S, Stableforth D, Prof Knox A, TOPIC Study Group.
    Lancet; 2003 Jun 17; 365(9459):573-8. PubMed ID: 15708100
    [Abstract] [Full Text] [Related]

  • 25. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
    Koo J, Tight R, Rajkumar V, Hawa Z.
    Am J Med; 1996 Aug 17; 101(2):177-83. PubMed ID: 8757358
    [Abstract] [Full Text] [Related]

  • 26. Once-daily dosing regimen for aminoglycoside plus betalactam combination therapy of serious lower respiratory tract infections.
    Paradisi F, Corti G.
    J Chemother; 1995 Aug 17; 7(4):338-43. PubMed ID: 8568544
    [Abstract] [Full Text] [Related]

  • 27. Once-daily dosing of aminoglycosides.
    Blaser J, König C.
    Eur J Clin Microbiol Infect Dis; 1995 Dec 17; 14(12):1029-38. PubMed ID: 8681976
    [Abstract] [Full Text] [Related]

  • 28. Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.
    Coulthard KP, Peckham DG, Conway SP, Smith CA, Bell J, Turnidge J.
    J Cyst Fibros; 2007 Apr 17; 6(2):125-30. PubMed ID: 16829216
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of a Once/Day Tobramycin Regimen to Achieve Target Concentrations in Adult Patients with Cystic Fibrosis.
    Staubes BA, Metzger NL, Walker SD, Peasah SK.
    Pharmacotherapy; 2016 Jun 17; 36(6):623-30. PubMed ID: 27138730
    [Abstract] [Full Text] [Related]

  • 30. Therapeutic drug monitoring of tobramycin: once-daily versus twice-daily dosage schedules.
    Sánchez-Alcaraz A, Vargas A, Quintana MB, Rocher A, Querol JM, Poveda JL, Hermenegildo M.
    J Clin Pharm Ther; 1998 Oct 17; 23(5):367-73. PubMed ID: 9875685
    [Abstract] [Full Text] [Related]

  • 31. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
    Canis F, Trivier D, Vic P, Ategbo S, Turck D, Husson MO.
    Pathol Biol (Paris); 1998 Jun 17; 46(6):449-51. PubMed ID: 9769880
    [Abstract] [Full Text] [Related]

  • 32. Comparing dosage adjustment methods for once-daily tobramycin in paediatric and adolescent patients with cystic fibrosis.
    Hennig S, Holthouse F, Staatz CE.
    Clin Pharmacokinet; 2015 Apr 17; 54(4):409-21. PubMed ID: 25403847
    [Abstract] [Full Text] [Related]

  • 33. National survey of extended-interval aminoglycoside dosing in pediatric cystic fibrosis pulmonary exacerbations.
    Prescott WA.
    J Pediatr Pharmacol Ther; 2011 Oct 17; 16(4):262-9. PubMed ID: 22768010
    [Abstract] [Full Text] [Related]

  • 34. Aminoglycosides: Single- or Multiple-daily Dosing? An Updated Qualitative Systematic Review of Randomized Trials on Toxicity and Efficacy.
    Karimzadeh I, Abdollahpour-Alitappeh M, Ghaffari S, Mahi-Birjand M, Barkhordari A, Alemzadeh E.
    Curr Mol Med; 2024 Oct 17; 24(11):1358-1373. PubMed ID: 37533241
    [Abstract] [Full Text] [Related]

  • 35. Minimisation of aminoglycoside toxicity in patients with cystic fibrosis.
    Wood PJ, Ioannides-Demos LL, Li SC, Williams TJ, Hickey B, Spicer WJ, Hooper RE, McLean AJ.
    Thorax; 1996 Apr 17; 51(4):369-73. PubMed ID: 8733487
    [Abstract] [Full Text] [Related]

  • 36. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
    Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH.
    J Antimicrob Chemother; 1997 Jun 17; 39(6):677-86. PubMed ID: 9222035
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization.
    van Velzen AJ, Bos AC, Touw DJ, Tiddens HA, Heijerman HG, Janssens HM.
    J Aerosol Med Pulm Drug Deliv; 2016 Jun 17; 29(3):273-80. PubMed ID: 26716357
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study.
    Master V, Roberts GW, Coulthard KP, Baghurst PA, Martin A, Roberts ME, Onishko CR, Martin AJ, Linke RJ, Holmes M, Jarvinen A, Kennedy D, Colebatch KA, Hansman D, Parsons DW.
    Pediatr Pulmonol; 2001 May 17; 31(5):367-76. PubMed ID: 11340683
    [Abstract] [Full Text] [Related]

  • 39. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
    Cheer SM, Waugh J, Noble S.
    Drugs; 2003 May 17; 63(22):2501-20. PubMed ID: 14609360
    [Abstract] [Full Text] [Related]

  • 40. Aminoglycoside monitoring in the once- or twice-daily era. The Dutch situation considered.
    Janknegt R.
    Pharm World Sci; 1993 Aug 20; 15(4):151-5. PubMed ID: 8220298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.